Tesoro Filler
Category
HA Filler
Origin
Korea
Options
Implant · Sub-Q · Deep · Fine
Available options
Interested in ordering Tesoro Filler? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Tesoro is a South Korean stabilised hyaluronic acid filler range for facial contouring, wrinkle correction and volumisation. It is made from high-purity, non-animal HA refined through a multi-phase purification process and is available in Fine, Deep, Sub-Q and Implant grades. Grades are offered with or without lidocaine.
How it works
A cross-linked/stabilised HA gel that restores volume and binds water for hydration and tissue support. Cross-linking increases cohesivity and durability, with viscosity stepped across grades so Fine corrects superficially while Sub-Q and Implant provide deep lift and contouring.
Indications
- Superficial wrinkles and lip refinement (Fine)
- Nasolabial folds and moderate-deep wrinkles (Deep)
- Deep volume and facial reshaping (Sub-Q)
- Non-surgical contouring/augmentation (Implant)
Key features
- Stabilised non-animal HA (20 mg/mL; Implant 24 mg/mL)
- Four grades (Implant/Sub-Q/Deep/Fine)
- 3-phase HA purification
- 0.3% lidocaine option
- Prefilled sterile syringes
Benefits
- Grade range covers fine lines to deep contouring
- Purification process supports tolerability
- Lidocaine option improves comfort
- Reversible with hyaluronidase
- Cost-competitive Korean sourcing for B2B ordering
Composition
20 mg/mL stabilised hyaluronic acid with 0.3% lidocaine option (Implant grade reported at 24 mg/mL); non-animal HA with multi-phase purification.
Usage & handling
Place Fine superficially, Deep in mid-to-deep dermis, Sub-Q/Implant in deep subcutaneous planes for volume and shaping. Avoid intravascular injection; use correct depth per grade. Keep hyaluronidase available for correction or vascular events. Single-use, store per label.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.